Cosciens Biopharma Inc(CSCI) - 2025 Q2 - Quarterly Report

Exhibit 99.1 COSCIENS Biopharma Announces Results of Virtual 2025 Meeting of Shareholders TORONTO, ONTARIO, June 30, 2025 – COSCIENS Biopharma Inc. (NASDAQ: CSCI; TSX: CSCI) ("COSCIENS" or the "Company"), a life sciences company developing and commercializing a diversified portfolio of cosmeceutical, nutraceutical and pharmaceutical products, today announced the voting results on the items of business considered at the virtual annual general and special meeting of shareholders of the Company (the "AGSM") he ...